PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-32.00%
Negative net income growth while 1113.HK stands at 56.79%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
9.87%
D&A growth well above 1113.HK's 8.66%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
118.55%
Deferred tax of 118.55% while 1113.HK is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
29.08%
SBC growth of 29.08% while 1113.HK is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-58.24%
Negative yoy working capital usage while 1113.HK is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-223.14%
Negative yoy usage while 1113.HK is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
40.18%
Some yoy increase while 1113.HK is negative at -44.49%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-11.66%
Negative yoy CFO while 1113.HK is 4.56%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-4.08%
Negative yoy CapEx while 1113.HK is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-110.39%
Both yoy lines negative, with 1113.HK at -5.01%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
No Data
No Data available this quarter, please select a different quarter.
-8.02%
We reduce yoy sales while 1113.HK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-200.00%
Both yoy lines negative, with 1113.HK at -200.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-76.73%
Both yoy lines negative, with 1113.HK at -55.71%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
We repay more while 1113.HK is negative at -438.25%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-99.85%
Negative yoy issuance while 1113.HK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.